Inclusion Criteria:
  -  Male and female subjects aged ≥18 years of age
  -  CSU diagnosis for ≥ 6 months prior to screening
  -  Presence of itch and hives for ≥6 consecutive weeks prior to screening in spite of use of non-sedating H1-antihistamines according to local Treatment guidelines during this time period
  -  UAS7 score (range 0-42) ≥16 and HSS7 score (range 0-21) ≥ 8 during 7 days prior to randomization (Day 1)
  -  Willing and able to complete an Urticaria Participant Daily eDiary (UPDD) for the duration of the study
Exclusion Criteria:
  -  Hypersensitivity to any of the study treatments
  -  Clearly defined predominant or sole trigger of their chronic urticaria (chronic inducible urticaria)
  -  Other diseases with symptoms of urticaria or angioedema
  -  Other skin disease associated with chronic itching that might influence in the investigators opinion the study evaluations and results,
  -  Known or suspected history of an ongoing, chronic or recurrent infectious disease including but not limited to opportunistic infections (eg tuberculosis, atypical mycobacterioses, listeriosis or aspergillosis), HIV, Hepatitis B/C.
  -  Pregnant or nursing (lactating) women
  -  Women of child-bearing potential not using highly effective methods of contraception
Other protocol-defined inclusion/exclusion criteria may apply.